| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/25/2004 | CN1477116A Novel human secretion-related membrane protion, its coding sequence and its application |
| 02/25/2004 | CN1477115A Novel human cyclin, its coding sequence and application |
| 02/25/2004 | CN1477114A Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
| 02/25/2004 | CN1477113A Recombinant human fatty acid oxidation protein, its production method and application |
| 02/25/2004 | CN1477112A Rice tiller control gene MOC1 and its application |
| 02/25/2004 | CN1477111A Transcription factor for regulating and controlling adverse-resistance of tomato, its coding gene and application |
| 02/25/2004 | CN1477110A Adverse-resistance transcription factor from tomato, its coding gene and application |
| 02/25/2004 | CN1477109A Transcription factor capable of regulating and controlling soybean adverse resistance, its coding gene and application |
| 02/25/2004 | CN1477108A Recombinant gE protein and its application for diagnosis of pseudo-rabies virus infection |
| 02/25/2004 | CN1476899A Multi-medicine medicine-resistant RNA interference medicine for resisting tumor |
| 02/25/2004 | CN1139658C Process for screening taxusol high output cell strains in culturing enqlish yew cells |
| 02/25/2004 | CN1139656C Quick high-effective separation and purification method of virus related to recombinant adenovirus and its application |
| 02/25/2004 | CN1139655C Immortal human ovary carcinoma cell strain and its establishment method |
| 02/25/2004 | CN1139653C Process for creating medicine screening system with ABC1 gene cell target to screen 3G medicine of cardiovascular disease |
| 02/25/2004 | CN1139600C Method for producing human milk ferritin utilizing transgenic animal milk gland |
| 02/24/2004 | USRE38446 Sucrose phosphate synthase (SPS), its process for preparation its cDNA, and utilization of cDNA to modify the expression of SPS in plant cells |
| 02/24/2004 | US6696623 Method of increasing growth and yield in plants |
| 02/24/2004 | US6696622 Introducing polynucleotide sequence encoding plant histone h2a protein to host plant, expressing sequence in sufficient amount to increase agrobacterium transformation efficiency |
| 02/24/2004 | US6696621 Conferring resistance to nourseothricin antibiotic in plant tissue |
| 02/24/2004 | US6696620 Immunoglobulin binding protein arrays in eukaryotic cells |
| 02/24/2004 | US6696561 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 02/24/2004 | US6696560 Retinoblastoma-like RRB gene of arabidopsis thaliana |
| 02/24/2004 | US6696559 Antimicrobial peptides and methods of use |
| 02/24/2004 | US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence |
| 02/24/2004 | US6696556 Genetic engineering |
| 02/24/2004 | US6696547 Mutant DEDD proteins for regulating apoptosis |
| 02/24/2004 | US6696424 Cytofectin dimers and methods of use thereof |
| 02/24/2004 | US6696420 Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein |
| 02/24/2004 | US6696415 Tubedown-1 (tbdn-1), a protein associated with acetyltransferase activity has been characterized and its cdna isolated; tbdn-1 regulates endothelial differentiation through protein acetylation; angiogenesis inhibitors |
| 02/24/2004 | US6696408 Administering glycosylated polypeptides as antiepileptics and anticonvulsants or for prophylaxis of psychological disorders |
| 02/24/2004 | US6696303 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 02/24/2004 | US6696295 Transducing phages |
| 02/24/2004 | US6696293 Process for producing carotenoids and biological materials useful therefor |
| 02/24/2004 | US6696292 Genes encoding sulfate assimilation proteins |
| 02/24/2004 | US6696290 Genetic engineered multimeric proteins having extracellular domains of oncogenes which code transmembrane receptors, used as competitive antagonists or agonists of neuregulins; anticarcinogenic agents |
| 02/24/2004 | US6696289 Vector having nongenomic sequences coding for multiple cloning site and 3c-protease cleavage site between first and second amino acids of long polyprotein of sabin 1 poliovirus cdna |
| 02/24/2004 | US6696282 Fusarium sporotrichioides strains for production of lycopene |
| 02/24/2004 | US6696278 Method for transfer of DNA segments |
| 02/24/2004 | US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein |
| 02/24/2004 | US6696268 Production and use of antimicrobial agents |
| 02/24/2004 | US6696267 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 02/24/2004 | US6696263 PCNA associated cell cycle proteins, compositions and methods of use |
| 02/24/2004 | US6696260 Methods to identify growth differentiation factor (GDF) binding proteins |
| 02/24/2004 | US6696257 G protein-coupled receptors from the rat and human |
| 02/24/2004 | US6696254 Detection and identification of enteric bacteria |
| 02/24/2004 | US6696252 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
| 02/24/2004 | US6696251 Selection of sequences with desirable binding properties |
| 02/24/2004 | US6696250 Catalyzing cleavage with higher sequence specificity |
| 02/24/2004 | US6696248 Protein/(poly)peptide libraries |
| 02/24/2004 | US6696246 Allowing stringent wash conditions reducing background signals without loss of hybrids |
| 02/24/2004 | US6696245 Methods for selecting functional polypeptides |
| 02/24/2004 | US6696242 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 02/24/2004 | US6696081 Lipids where the glycerol backbone is replaced with a carbohydrate; conjugates; drug delivery |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6696061 Binds human major histocompatibility complex (mhc) class ii allotype |
| 02/24/2004 | US6696038 Cationic lipopolymer as biocompatible gene delivery agent |
| 02/24/2004 | US6695236 Process and device for the extraction of DNA, RNA and proteins from biological samples |
| 02/24/2004 | US6695015 Ultralow expansion brake rubber hose and its production method |
| 02/24/2004 | CA2352802C Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
| 02/24/2004 | CA2250014C Asymmetric benzoxanthene dyes |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/24/2004 | CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/24/2004 | CA2119557C Selective restriction fragment amplification: a general method for dna fingerprinting |
| 02/24/2004 | CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus |
| 02/22/2004 | CA2437979A1 Molecular constructs and methods of use for detection of biochemical reactions |
| 02/19/2004 | WO2004015417A1 A method and agents useful for same |
| 02/19/2004 | WO2004015395A2 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | WO2004015142A1 Uncoupling of dna propagation and expression of protein for phage display |
| 02/19/2004 | WO2004015130A2 Modulators of rabggt and methods of use thereof |
| 02/19/2004 | WO2004015127A2 Anticodon-based libraries and molecules for the specific shotgun and/or direct targeting of, and/or interaction with cells, tissues, surfaces, materials, molecules, and energy fields |
| 02/19/2004 | WO2004015126A2 Antisense modulation of edg1 expression |
| 02/19/2004 | WO2004015125A1 Process for preparing peptides with anti-hypertensive properties |
| 02/19/2004 | WO2004015124A1 Process for the production of a heterologous protein |
| 02/19/2004 | WO2004015123A1 Tissue specific expression of exogenous proteins in transgenic chickens |
| 02/19/2004 | WO2004015118A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | WO2004015117A2 Targeted gene modification by single-stranded dna oligonucleotides |
| 02/19/2004 | WO2004015116A1 Thermolabile caffeine fraction of tea leaves and use of this fraction in an efficient method of introducing agrobacterium-mediated genetic transformation in plants |
| 02/19/2004 | WO2004015115A1 Plastid transformation using modular vectors |
| 02/19/2004 | WO2004015114A2 Heterologous expression system comprising a b. subtilis promoter |
| 02/19/2004 | WO2004015113A2 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | WO2004015111A1 Staphylococcal nuclease fusion proteins for the production of recombinant peptides |
| 02/19/2004 | WO2004015110A1 Sugar chain synthase gene |
| 02/19/2004 | WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use |
| 02/19/2004 | WO2004015108A1 Mammalian grainyhead transcription factors |
| 02/19/2004 | WO2004015107A2 Further novel forms of interfering rna molecules |
| 02/19/2004 | WO2004015106A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | WO2004015105A1 Dna shuflling |
| 02/19/2004 | WO2004015104A1 Method of diagnosing risk of restenosis after coronary angioplasty |
| 02/19/2004 | WO2004015102A1 Olfactory ensheathing cells (oecs) in an extracellular matrix for use in axon regeneration |
| 02/19/2004 | WO2004015101A1 Method of transferring selected molecule into target cells, method of cell-fusing target cells and plasma exposure device to be used in these methods |
| 02/19/2004 | WO2004015100A1 Method of judging inflammatory disease |
| 02/19/2004 | WO2004015098A2 Rhesus epithelial cell adhesion molecule, nucleic acid encoding the same, and uses thereof |
| 02/19/2004 | WO2004015095A1 MODIFIED CYTOCHROME c OXIDASE AND MITOCHONDRIA |
| 02/19/2004 | WO2004015094A1 Process for the preparation of l-3,4-dihydroxyphenylalanine by aerobic fermentation of a microorganism |
| 02/19/2004 | WO2004015093A1 Method for producing cell lines and organs by means of differentiable cells |
| 02/19/2004 | WO2004015092A1 Method for producing stem cells using morulae or blastocysts |
| 02/19/2004 | WO2004015089A2 Polyionic organic acid formulations |
| 02/19/2004 | WO2004015088A2 Transposon-based transformation system |
| 02/19/2004 | WO2004015087A2 Eukaryotic genes involved in adult lifespan regulation |
| 02/19/2004 | WO2004015086A2 Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product |